These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34080968)

  • 1. Pre-Clinical Activity of Amino-Alcohol Dimeric Naphthoquinones as Potential Therapeutics for Acute Myeloid Leukemia.
    Ferraris D; Lapidus R; Truong P; Bollino D; Carter-Cooper B; Lee M; Chang E; LaRossa-Garcia M; Dash S; Gartenhaus R; Choi EY; Kipe O; Lam V; Mason K; Palmer R; Williams E; Ambulos N; Kamangar F; Zhang Y; Kapadia B; Jing Y; Emadi A
    Anticancer Agents Med Chem; 2022; 22(2):239-253. PubMed ID: 34080968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, characterization and antineoplastic activity of bis-aziridinyl dimeric naphthoquinone - A novel class of compounds with potent activity against acute myeloid leukemia cells.
    Carter-Cooper BA; Fletcher S; Ferraris D; Choi EY; Kronfli D; Dash S; Truong P; Sausville EA; Lapidus RG; Emadi A
    Bioorg Med Chem Lett; 2017 Jan; 27(1):6-10. PubMed ID: 27890379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of ortho-naphthoquinones as anti-AML agents by highly efficient oxidation of phenols.
    Huang H; Yan M; Chen J; Yuan B; Chen G; Cheng S; Huang D; Gao Z; Cao C
    Bioorg Chem; 2019 May; 86():97-102. PubMed ID: 30685647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the Mechanisms of Action of Naphthoquinone-Based Anti-Acute Myeloid Leukemia Chemotherapeutics.
    Lee MH; Lapidus RG; Ferraris D; Emadi A
    Molecules; 2019 Aug; 24(17):. PubMed ID: 31466259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxylated Dimeric Naphthoquinones Increase the Generation of Reactive Oxygen Species, Induce Apoptosis of Acute Myeloid Leukemia Cells and Are Not Substrates of the Multidrug Resistance Proteins ABCB1 and ABCG2.
    Lapidus RG; Carter-Cooper BA; Sadowska M; Choi EY; Wonodi O; Muvarak N; Natarajan K; Pidugu LS; Jaiswal A; Toth EA; Rassool FV; Etemadi A; Sausville EA; Baer MR; Emadi A
    Pharmaceuticals (Basel); 2016 Jan; 9(1):. PubMed ID: 26797621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors.
    Kumar S; Malachowski WP; DuHadaway JB; LaLonde JM; Carroll PJ; Jaller D; Metz R; Prendergast GC; Muller AJ
    J Med Chem; 2008 Mar; 51(6):1706-18. PubMed ID: 18318466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Napabucasin (BBI608) eliminate AML cells in vitro and in vivo via inhibition of Stat3 pathway and induction of DNA damage.
    Bi S; Chen K; Feng L; Fu G; Yang Q; Deng M; Zhao H; Li Z; Yu L; Fang Z; Xu B
    Eur J Pharmacol; 2019 Jul; 855():252-261. PubMed ID: 31085238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abivertinib synergistically strengthens the anti-leukemia activity of venetoclax in acute myeloid leukemia in a BTK-dependent manner.
    Huang S; Li C; Zhang X; Pan J; Li F; Lv Y; Huang J; Ling Q; Ye W; Mao S; Huang X; Jin J
    Mol Oncol; 2020 Oct; 14(10):2560-2573. PubMed ID: 32519423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superior anti-tumor activity of the MDM2 antagonist idasanutlin and the Bcl-2 inhibitor venetoclax in p53 wild-type acute myeloid leukemia models.
    Lehmann C; Friess T; Birzele F; Kiialainen A; Dangl M
    J Hematol Oncol; 2016 Jun; 9(1):50. PubMed ID: 27353420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxicity of Synthesized 1,4-Naphthoquinone Oxime Derivatives on Selected Human Cancer Cell Lines.
    Zhang Q; Dong J; Cui J; Huang G; Meng Q; Li S
    Chem Pharm Bull (Tokyo); 2018; 66(6):612-619. PubMed ID: 29863062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel ROS-activated agents utilize a tethered amine to selectively target acute myeloid leukemia.
    Bell-Horwath TR; Vadukoot AK; Thowfeik FS; Li G; Wunderlich M; Mulloy JC; Merino EJ
    Bioorg Med Chem Lett; 2013 May; 23(10):2951-4. PubMed ID: 23578690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in mice.
    Anstee NS; Bilardi RA; Ng AP; Xu Z; Robati M; Vandenberg CJ; Cory S
    Cell Death Differ; 2019 Jul; 26(7):1316-1331. PubMed ID: 30470795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imipridone ONC212 activates orphan G protein-coupled receptor GPR132 and integrated stress response in acute myeloid leukemia.
    Nii T; Prabhu VV; Ruvolo V; Madhukar N; Zhao R; Mu H; Heese L; Nishida Y; Kojima K; Garnett MJ; McDermott U; Benes CH; Charter N; Deacon S; Elemento O; Allen JE; Oster W; Stogniew M; Ishizawa J; Andreeff M
    Leukemia; 2019 Dec; 33(12):2805-2816. PubMed ID: 31127149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 225Ac-labeled CD33-targeting antibody reverses resistance to Bcl-2 inhibitor venetoclax in acute myeloid leukemia models.
    Garg R; Allen KJH; Dawicki W; Geoghegan EM; Ludwig DL; Dadachova E
    Cancer Med; 2021 Feb; 10(3):1128-1140. PubMed ID: 33347715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Target ROS to induce apoptosis and cell cycle arrest by 5,7-dimethoxy-1,4-naphthoquinone derivative.
    Li K; Wang B; Zheng L; Yang K; Li Y; Hu M; He D
    Bioorg Med Chem Lett; 2018 Feb; 28(3):273-277. PubMed ID: 29305189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-acute myeloid leukemia activity of 2-chloro-3-alkyl-1,4-naphthoquinone derivatives through inducing mtDNA damage and GSH depletion.
    Li K; Yang K; Zheng L; Li Y; Wang Q; Lin R; He D
    Bioorg Med Chem; 2018 Aug; 26(14):4191-4200. PubMed ID: 30007564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor Effect of Pomolic Acid in Acute Myeloid Leukemia Cells Involves Cell Death, Decreased Cell Growth and Topoisomerases Inhibition.
    Pereira MXG; Hammes ASO; Vasconcelos FC; Pozzo AR; Pereira TH; Caffarena ER; Gattass CR; Maia RC
    Anticancer Agents Med Chem; 2018; 18(10):1457-1468. PubMed ID: 29651965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and anticancer activity of 2-amidomethoxy-1,4-naphthoquinones and its conjugates with Biotin/polyamine.
    Manickam M; Boggu PR; Pillaiyar T; Nam YJ; Abdullah M; Lee SJ; Kang JS; Jung SH
    Bioorg Med Chem Lett; 2021 Jan; 31():127685. PubMed ID: 33197549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A synthetic cell-penetrating peptide derived from nuclear localization signal of EPS8 exerts anticancer activity against acute myeloid leukemia.
    Chen Y; Xie X; Wu A; Wang L; Hu Y; Zhang H; Li Y
    J Exp Clin Cancer Res; 2018 Jan; 37(1):12. PubMed ID: 29357910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic enamine naphthoquinone derived from lawsone as cytotoxic agents assessed by in vitro and in silico evaluations.
    Lemos BC; Westphal R; Filho EV; Fiorot RG; Carneiro JWM; Gomes ACC; Guimarães CJ; de Oliveira FCE; Costa PMS; Pessoa C; Greco SJ
    Bioorg Med Chem Lett; 2021 Dec; 53():128419. PubMed ID: 34715305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.